Keloid
https://en.wikipedia.org/wiki/Keloid
☆ AI Dermatology — Free ServiceKatika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa. relevance score : -100.0%
References
Keloid 29939676 NIH
Keloidi huundwa kutokana na uponyaji usio wa kawaida baada ya kuumia kwa ngozi au kuvimba. Sababu za kijeni na kimazingira huchangia ukuaji wao, huku viwango vya juu zaidi vya watu wenye ngozi nyeusi wa asili ya Kiafrika, Asia, na Rico. Keloidi hutokea wakati fibroblasts zinapofanya kazi kupita kiasi, huzalisha collagen nyingi na kusababisha ukuaji. Hii husababisha kuundwa kwa vifurushi vikubwa vya kolajeni visivyo vya kawaida vinavyojulikana kama keloidal collagen, pamoja na ongezeko la nyuzinyuzi. Kliniki, keloidi huonekana kama vinundu thabiti, vya mpira, katika maeneo yaliyojeruhiwa hapo awali. Tofauti na makovu ya kawaida, keloidi huenea zaidi ya eneo la asili ya kiwewe. Wagonjwa wanaweza kupata maumivu, kuwasha, au kuchoma. Matibabu mbalimbali yanapatikana, ikiwa ni pamoja na sindano za steroid, cryotherapy, upasuaji, radiotherapy, na laser therapy.
Keloids result from abnormal wound healing in response to skin trauma or inflammation. Keloid development rests on genetic and environmental factors. Higher incidences are seen in darker skinned individuals of African, Asian, and Hispanic descent. Overactive fibroblasts producing high amounts of collagen and growth factors are implicated in the pathogenesis of keloids. As a result, classic histologic findings demonstrate large, abnormal, hyalinized bundles of collagen referred to as keloidal collagen and numerous fibroblasts. Keloids present clinically as firm, rubbery nodules in an area of prior injury to the skin. In contrast to normal or hypertrophic scars, keloidal tissue extends beyond the initial site of trauma. Patients may complain of pain, itching, or burning. Multiple treatment modalities exist although none are uniformly successful. The most common treatments include intralesional or topical steroids, cryotherapy, surgical excision, radiotherapy, and laser therapy.
Keloid treatments: an evidence-based systematic review of recent advances 36918908 NIH
Utafiti wa hivi karibuni unapendekeza kuwa jeli ya silikoni au karatasi pamoja na sindano za corticosteroid ndizo matibabu ya awali yanayopendekezwa kwa keloidi. Matibabu ya ziada kama vile intralesional 5-fluorouracil (5-FU), bleomycin, au verapamil pia yanaweza kuzingatiwa, ingawa ufanisi wake unatofautiana. Tiba ya laser, inapojumuishwa na sindano za corticosteroid au steroids za ndani chini ya uzuiaji, inaweza kuongeza kupenya kwa dawa. Kwa keloidi zilizokaidi, upasuaji uliofuatiwa na tiba ya mionzi ya papo hapo umeonyesha kuwa ni wa ufanisi. Hatimaye, matumizi ya karatasi ya silikoni na tiba ya shinikizo yameuthibitishwa kupunguza uwezekano wa keloidi kurudi tena.
Current literature supports silicone gel or sheeting with corticosteroid injections as first-line therapy for keloids. Adjuvant intralesional 5-fluorouracil (5-FU), bleomycin, or verapamil can be considered, although mixed results have been reported with each. Laser therapy can be used in combination with intralesional corticosteroids or topical steroids with occlusion to improve drug penetration. Excision of keloids with immediate post-excision radiation therapy is an effective option for recalcitrant lesions. Finally, silicone sheeting and pressure therapy have evidence for reducing keloid recurrence.
Keloids: a review of therapeutic management 32905614 NIH
Kwa sasa, hakuna matibabu ya njia moja ambayo yanahakikisha kiwango cha chini cha kurudi kwa keloidi. Hata hivyo, chaguzi zinazojitokeza, kama vile matumizi ya leza kando ya steroids au mchanganyiko wa 5-fluorouracil na steroids, yanaonyesha ahadi. Utafiti wa siku zijazo unaweza kuangalia jinsi matibabu mapya, kama vile upandikizaji wa mafuta ya kiotomatiki au matibabu ya msingi wa seli, yanavyofanya kazi katika kudhibiti keloidi.
There continues to be no gold standard of treatment that provides a consistently low recurrence rate; however the increasing number of available treatments and synergistic combinations of these treatments (i.e., laser-based devices in combination with intralesional steroids, or 5-fluorouracil in combination with steroid therapy) is showing favorable results. Future studies could target the efficacy of novel treatment modalities (i.e., autologous fat grafting or stem cell-based therapies) for keloid management.
Scar Revision 31194458 NIH
Makovu ni sehemu ya kawaida ya mchakato wa uponyaji baada ya majeraha ya ngozi. Kwa kawaida, makovu yanapaswa kuwa gorofa, nyembamba, na kufanana na rangi ya ngozi. Sababu nyingi zinaweza kusababisha uponyaji mbaya wa jeraha, kama vile maambukizi, kupungua kwa mtiririko wa damu, ischemia, na kiwewe. Makovu ambayo ni mazito, meusi zaidi kuliko ngozi inayozunguka, au yanayosinyaa kupita kiasi, yanaweza kusababisha matatizo makubwa katika utendaji wa kimwili na afya ya kihisia.
Scars are a natural and normal part of healing following an injury to the integumentary system. Ideally, scars should be flat, narrow, and color-matched. Several factors can contribute to poor wound healing. These include but are not limited to infection, poor blood flow, ischemia, and trauma. Proliferative, hyperpigmented, or contracted scars can cause serious problems with both function and emotional well-being.
Keloid huonekana mara nyingi zaidi kwa watu wa asili ya Kiafrika, Asia, au Kihispania. Watu wenye umri kati ya miaka 10 na 30 wana uwezekano mkubwa wa kuendeleza keloid kuliko wazee.
Ingawa kwa kawaida hutokea kwenye eneo la jeraha, keloid pia inaweza kujitokeza bila sababu. Inaweza kutokea kwenye eneo la kutoboa na hata kutokana na kitu rahisi kama madoa (pimple) au maumivu ya awali. Inaweza pia kusababishwa na chunusi kali, kizuizi cha tetekuwanga, majeraha yanayorudiwa katika eneo lile lile, mvutano mwingi wa ngozi wakati wa kufungwa kwa jeraha, au mwili wa kigeni kwenye jeraha.
Keloid inaweza kutokea baada ya upasuaji. Hutokea zaidi katika maeneo fulani, kama kifua cha kati (kutokana na sternotomia), mgongo na mabega (kawaida husababishwa na chunusi), na sehemu za masikio (kutokana na kutoboa masikio). Inaweza pia kutokea baada ya kutoboa mwili. Maeneo yanayojulikana ni masikio, mikono, eneo la pelvic, na juu ya mfupa wa kola.
Matibabu yanayopatikana ni: tiba ya shinikizo, karatasi ya gel ya silikoni, acetonide ya triamcinolone ya ndani ya vidonda, upasuaji wa kufyatua, mionzi, tiba ya leza, Interferon, 5-FU, na upasuaji wa kukata.
○ Matibabu
Makovu ya hypertrophic yanaweza kuboreka kwa sindano 5 hadi 10 za intralesional steroid ndani ya mwezi 1.
#Triamcinolone intralesional injection
Tiba ya laser inaweza kujaribiwa kwa erithema inayohusishwa na keloid, lakini sindano za triamcinolone zinaweza pia kuboresha erithema kwa kupunguza keloid.
#Dye laser (e.g. V-beam)